Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20-69 years.
OBJECTIVE
To obtain correct evaluation of the prevalence rate of diabetes mellitus and impaired fasting glycemia (IFG) in Hungary.


METHODS
The study was performed on a nationally representative sample covered by the Hungarian General Practitioners' Morbidity Sentinel Stations Program. The source population consisted of all persons aged 20-69 years who were registered with the participating centers. The prevalence rates were adjusted to age and sex distribution of the total Hungarian population. Fasting blood samples of 1803 participants were evaluated. Response rate was 90.7%.


RESULTS
In addition to 130 (7.21%) patients with established diabetes, 26 participants with newly diagnosed diabetes were found, resulting in a total crude diabetes prevalence of 8.65% (men: 11.16%; women: 6.41%; P<0.001). After weighting for age and sex, the prevalence rate of diabetes in participants aged 20-69 years should be set at 7.47% (95% confidence interval [CI], 6.26-8.69) (men: 9.49%; 95% CI, 7.52-11.46; women: 5.58%; 95% CI, 4.12-7.04). In addition to 41 (2.27%) patients with established IFG (fasting blood glucose: 6.1-6.9 mmol/L), 47 participants with newly diagnosed IFG were found, resulting in a total crude IFG prevalence of 4.88% (men: 6.11%; women: 3.78%; P=0.022). After making corrections for weighting age and sex, the total IFG prevalence rate in participants aged 20-69 years should be set at 4.39% (95% CI, 3.44-5.34) (men: 5.52%; 95% CI, 3.99-7.06; women: 3.33%; 95% CI, 2.19-4.47).


CONCLUSIONS
The prevalence rate of diabetes and IFG in Hungary is higher than previously estimated by experts and authorities. The present data may serve as a base for comparative investigations in the future.
Jermendy
György
G
Bajcsy-Zsilinszky Hospital, 3rd Medical Department, Maglodi ut 89-91, Budapest, 1106, Hungary. gyjermendy@mail.datanet.hu
Nádas
Judit
J
Szigethy
Endre
E
Széles
György
G
Nagy
Attila
A
Hídvégi
Tibor
T
Paragh
György
G
Adány
Róza
R
D000328:Adult; D017677:Age Distribution; D000368:Aged; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000453:epidemiology*; D005260:Female; D018149:Glucose Intolerance / Q000453:epidemiology*; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D008875:Middle Aged; D015995:Prevalence; D017678:Sex Distribution
Neth J Med. 1997 Jul;51(1):1-9
9260484
Diabetes Care. 2004 May;27(5):1047-53
15111519
Nature. 2001 Dec 13;414(6865):782-7
11742409
Exp Clin Endocrinol Diabetes. 2009 Jul;117(7):350-3
19536734
Diabetes Res Clin Pract. 2008 Aug;81(2):263-7
18534707
Diabetologia. 2005 Aug;48(8):1459-63
16007413
Diabetes Res Clin Pract. 2008 Aug;81(2):238-42
18495284
Diabet Med. 2007 May;24(5):451-63
17470191
Diabetologia. 2010 Jan;53(1):10-20
19890624
Diabetes Care. 2003 Nov;26(11):3160-7
14578255
Diabetes. 1995 Nov;44(11):1249-58
7589820
Pol Arch Med Wewn. 2001 Sep;106(3):771-9
11928585
Diabetologia. 2004 Aug;47(8):1396-402
15278279
Pol Arch Med Wewn. 2001 Sep;106(3):781-6
11928586
Eur J Public Health. 2005 Feb;15(1):26-32
15788800
Lancet. 2009 Jun 27;373(9682):2215-21
19515410
JAMA. 2001 May 16;285(19):2486-97
11368702
Diabetes Care. 1992 Jul;15(7):815-9
1516497